Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
11.14
+0.76 (7.32%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $688 million as of October 27, 2025. Its market cap has increased by 133.57% in one year.
Market Cap
688.00M
Enterprise Value
438.54M
1-Year Change
133.57%
Ranking
Category
Stock Price
$11.14
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $688.00M, a decrease of -18.61%. That is a compound annual growth rate of -4.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 688.00M | 61.36% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |